8-K: Rallybio Announces 1-for-8 Reverse Stock Split

Rallybio Corporation will implement a 1-for-8 reverse stock split of its common stock effective February 6, 2026, following stockholder approval.

Summary

• Rallybio Corporation filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a 1-for-8 reverse stock split of its issued and outstanding common stock.
• The reverse stock split will be effective at 12:01 a.m., Eastern Time, on February 6, 2026.
• The company expects its common stock to begin trading on a post-split basis on February 6, 2026, under CUSIP number 75120L 209.
• Stockholders approved a proposal to amend the Certificate of Incorporation for a reverse stock split at a Special Meeting held on January 26, 2026.
• The voting results for the proposal were 34,507,021 'For', 464,514 'Against', and 11,939 'Abstaining'.
• No fractional shares will be issued; instead, holders who would otherwise be entitled to a fractional share will receive a cash payment based on the closing price of the common stock on The Nasdaq Capital Market on the business day immediately preceding the effective date.
• The par value of the common stock will remain $0.0001 per share after the reverse stock split.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative procedural action. While it addresses potential listing compliance issues and can improve stock perception, reverse splits often follow periods of significant stock price decline, which is generally a negative indicator for investors.

Future Outlook

The reverse stock split will become effective on February 6, 2026, with post-split trading expected to commence on the same day.

Management Comments

• Jonathan I. Lieber, Chief Financial Officer and Treasurer, signed the report on behalf of Rallybio Corporation.
• Stephen Uden, M.D., Chief Executive Officer, signed the Certificate of Amendment on behalf of Rallybio Corporation.

Industry Context

StockSavvy.ai notes that reverse stock splits are a common corporate action, particularly for biotechnology companies like Rallybio, which often experience significant stock price volatility during their development phases. Such splits are frequently undertaken to increase the per-share trading price, which can help meet minimum bid price requirements for continued listing on exchanges like Nasdaq and potentially make the stock more appealing to institutional investors who may have policies against investing in 'penny stocks.' While not explicitly stated in the filing, this action typically aims to improve the company's market perception and compliance with exchange rules.

Comparison to Industry Standards

• Reverse stock splits are a standard mechanism used by companies across various industries, including biotechnology, to adjust their share structure.
• The 1-for-8 ratio falls within the typical range (often 1-for-5 to 1-for-20) seen in similar corporate actions by other companies facing low stock prices or seeking to enhance market perception, such as those previously executed by companies like Sorrento Therapeutics (SRNE) or Mullen Automotive (MULN).
• The provision for cash in lieu of fractional shares is also a standard practice to simplify post-split shareholding and avoid issuing de minimis share amounts.

Corporate Governance

Stakeholder Impact

• Shareholders: The number of shares held by each shareholder will be reduced by a factor of eight. Fractional shares will be cashed out, potentially leading to a small cash payment for some shareholders. The per-share price is expected to increase proportionally.
• Exchange Listing: The reverse stock split is likely intended to help the company maintain compliance with minimum bid price requirements of the Nasdaq Capital Market.

Next Steps

• The reverse stock split will become effective at 12:01 a.m., Eastern Time, on February 6, 2026.
• Rallybio's common stock is expected to begin trading on a post-split basis on February 6, 2026.
• Shareholders holding pre-split stock certificates will be entitled to receive new certificates upon surrender to the transfer agent.
• Cash payments will be made to holders of fractional shares based on the closing price on the business day immediately preceding February 6, 2026.

Key Dates

Keywords

Rallybio, RLYB, reverse stock split, corporate action, stockholders meeting, common stock, Nasdaq, Certificate of Amendment, corporate governance